Delivery Order SPE2DB22D1202-SPE2DB24FUSN3
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $15,442.40 and a period of performance through April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The award, valued at $35,517.52, has an ultimate completion date of April 1, 2024. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,176,731 units of the RABAVERT rabies vaccine with diluents. The contract has a ceiling value of $1,930.30 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an...
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $10,357.47 contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract, valued at $5,790.90, has an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency awarded a firm-fixed-price delivery order contract worth $38,606.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RABAVERT rabies vaccine with diluents. This contract has a completion date of March 1, 2024 and was awarded on February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. This contract is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $2,895.45 order has a completion date of March 6, 2024 and was awarded on March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key pharmaceutical supplier to DLA, holding a $999,999,999.00 indefinite delivery contract to deliver a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT RABIES VACC W-DILUENTS. The contract has a potential value of $1,930.30 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $19,303 contract has a completion date of March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of pharmaceuticals and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RABAVERT rabies vaccine with diluents. The $3,860.60 contract has a performance period through March 25, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUSN3Delivery Order
The Defense Logistics Agency has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a potential value of $27,024.20 and a performance period through March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to the Department of Defense through the DLA Troop Support Medical program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.0k | 3/5/24 |